Literature DB >> 8043403

Mucosal lichen sclerosus/lichen planus overlap syndromes.

P Marren1, P Millard, Y Chia, F Wojnarowska.   

Abstract

Lichen sclerosus and lichen planus affecting cutaneous sites are easily distinguishable clinical. Clinical signs on mucosal sites, however, may not allow differentiation between these diseases, and reliance is frequently placed on histopathological findings. We report a series of seven patients with clinical evidence of coexisting vulval lichen sclerosus and lichenoid oral lesions. All patients had vulval biopsies, and four had oral biopsies. Histology of all the vulval biopsy specimens showed features consistent with lichen sclerosus. Two of these patients developed vulval intraepithelial neoplasia during the course of their disease, and one progressed to a well-differentiated squamous carcinoma. Histology of the oral lesions showed features that were predominantly those of lichen planus. There are, however, few reports of histologically proven oral lichen sclerosus. Variations in histopathological descriptions of lichen sclerosus, depending on duration of disease, have been reported, particularly with regard to the position of the inflammatory infiltrate in relation to the dermo-epidermal junction. We believe that these patients may have oral lichen sclerosus, or at the very least make up a distinctive group who need to be identified and followed up, as their risk of oral dysplasia is unknown.

Entities:  

Mesh:

Year:  1994        PMID: 8043403     DOI: 10.1111/j.1365-2133.1994.tb08468.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  2 in total

1.  Anogenital lichen sclerosus in women.

Authors:  R H Thomas; C M Ridley; D H McGibbon; M M Black
Journal:  J R Soc Med       Date:  1996-12       Impact factor: 18.000

2.  Diagnostic criteria for erosive lichen planus affecting the vulva: an international electronic-Delphi consensus exercise.

Authors:  R C Simpson; K S Thomas; P Leighton; R Murphy
Journal:  Br J Dermatol       Date:  2013-08       Impact factor: 9.302

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.